Form DEFA14A SEELOS THERAPEUTICS,
Tweet
Share
E-mailUNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 14A
PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
Filed by the Registrant ☒
|
|
|
Filed by a Party other than the Registrant ☐
|
Check the appropriate box:
|
☐
|
|
|
Preliminary Proxy Statement
|
|
☐
|
|
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
☐
|
|
|
Definitive Proxy Statement
|
|
☒
|
|
|
Definitive Additional Materials
|
|
☐
|
|
|
Soliciting Material Pursuant to §240.14a-12
|
SEELOS THERAPEUTICS, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
|
☒
|
|
|
No fee required.
|
|
☐
|
|
|
Fee paid previously with preliminary materials.
|
|
☐
|
|
|
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
**** IMPORTANT REMINDER ****
Dear Seelos Therapeutics, Inc. Stockholder:
By now, you should have received your proxy materials for the 2022 Annual Meeting of Stockholders of Seelos Therapeutics, Inc., which is scheduled to be held virtually, via
live webcast, on May 20, 2022. You are receiving this reminder letter because your votes were not yet processed at the time that this letter was mailed. If you have already voted, we would like to thank you for your vote.
Your vote is very important. PLEASE CAST YOUR VOTE TODAY. The fastest and easiest way to vote is by telephone or over the Internet.
Instructions on how to vote your shares over the telephone or Internet are enclosed with this letter.
WE URGE YOU TO EXERCISE YOUR RIGHT TO VOTE TODAY.
Your Board recommends that you vote “FOR” ALL proposals. Even if you plan on attending the virtual meeting, we urge you to vote your
shares now, so they can be tabulated prior to the meeting.
****PLEASE VOTE TODAY****
If you have questions or need help voting your shares, please call our proxy solicitation firm, Morrow Sodali LLC at 1-877-787-9239.
Thank you for your investment in Seelos Therapeutics, Inc. and for taking the time to vote your shares.
Sincerely,
Raj Mehra, Ph.D.
Chief Executive Officer
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dimensional Fund Advisors Ltd. : Form 8.3 - BARRATT DEVELOPMENTS PLC - Ordinary Shares
- Åsa Vilsson new CFO at Elanders
- Company announcement no 7/2024 Annual account 2023
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
